+1 (704) 266-3234

United States Metabotropic Glutamate Receptor 2 Market Report & Forecast 2021-2027

Published on: Oct 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 94

United States Metabotropic Glutamate Receptor 2 Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
United States Metabotropic Glutamate Receptor 2 Market Segment Percentages, By Type, 2020 (%)
LY-2607540
BMT-133218
DT-2442
JNJ-40411813
Others

United States Metabotropic Glutamate Receptor 2 Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
United States Metabotropic Glutamate Receptor 2 Market Segment Percentages, By Application, 2020 (%)
Anxiety Disorders
Depression
Schizophrenia
Chronic Pain
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metabotropic Glutamate Receptor 2 revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Metabotropic Glutamate Receptor 2 revenues share in United States market, 2020 (%)
Key companies Metabotropic Glutamate Receptor 2 sales in United States market, 2016-2021 (Estimated), (K Pcs)
Key companies Metabotropic Glutamate Receptor 2 sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc

1 Introduction to Research & Analysis Reports
1.1 Metabotropic Glutamate Receptor 2 Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Metabotropic Glutamate Receptor 2 Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States Metabotropic Glutamate Receptor 2 Overall Market Size
2.1 United States Metabotropic Glutamate Receptor 2 Market Size: 2021 VS 2027
2.2 United States Metabotropic Glutamate Receptor 2 Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Metabotropic Glutamate Receptor 2 Sales: 2016-2027

3 Company Landscape
3.1 Top Metabotropic Glutamate Receptor 2 Players in United States Market
3.2 Top United States Metabotropic Glutamate Receptor 2 Companies Ranked by Revenue
3.3 United States Metabotropic Glutamate Receptor 2 Revenue by Companies
3.4 United States Metabotropic Glutamate Receptor 2 Sales by Companies
3.5 United States Metabotropic Glutamate Receptor 2 Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Metabotropic Glutamate Receptor 2 Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Metabotropic Glutamate Receptor 2 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Metabotropic Glutamate Receptor 2 Players in United States Market
3.8.1 List of Tier 1 Metabotropic Glutamate Receptor 2 Companies in United States
3.8.2 List of Tier 2 and Tier 3 Metabotropic Glutamate Receptor 2 Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Metabotropic Glutamate Receptor 2 Market Size Markets, 2021 & 2027
4.1.2 LY-2607540
4.1.3 BMT-133218
4.1.4 DT-2442
4.1.5 JNJ-40411813
4.1.6 Others
4.2 By Type - United States Metabotropic Glutamate Receptor 2 Revenue & Forecasts
4.2.1 By Type - United States Metabotropic Glutamate Receptor 2 Revenue, 2016-2021
4.2.2 By Type - United States Metabotropic Glutamate Receptor 2 Revenue, 2022-2027
4.2.3 By Type - United States Metabotropic Glutamate Receptor 2 Revenue Market Share, 2016-2027
4.3 By Type - United States Metabotropic Glutamate Receptor 2 Sales & Forecasts
4.3.1 By Type - United States Metabotropic Glutamate Receptor 2 Sales, 2016-2021
4.3.2 By Type - United States Metabotropic Glutamate Receptor 2 Sales, 2022-2027
4.3.3 By Type - United States Metabotropic Glutamate Receptor 2 Sales Market Share, 2016-2027
4.4 By Type - United States Metabotropic Glutamate Receptor 2 Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Metabotropic Glutamate Receptor 2 Market Size, 2021 & 2027
5.1.2 Anxiety Disorders
5.1.3 Depression
5.1.4 Schizophrenia
5.1.5 Chronic Pain
5.1.6 Others
5.2 By Application - United States Metabotropic Glutamate Receptor 2 Revenue & Forecasts
5.2.1 By Application - United States Metabotropic Glutamate Receptor 2 Revenue, 2016-2021
5.2.2 By Application - United States Metabotropic Glutamate Receptor 2 Revenue, 2022-2027
5.2.3 By Application - United States Metabotropic Glutamate Receptor 2 Revenue Market Share, 2016-2027
5.3 By Application - United States Metabotropic Glutamate Receptor 2 Sales & Forecasts
5.3.1 By Application - United States Metabotropic Glutamate Receptor 2 Sales, 2016-2021
5.3.2 By Application - United States Metabotropic Glutamate Receptor 2 Sales, 2022-2027
5.3.3 By Application - United States Metabotropic Glutamate Receptor 2 Sales Market Share, 2016-2027
5.4 By Application - United States Metabotropic Glutamate Receptor 2 Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Addex Therapeutics Ltd
6.1.1 Addex Therapeutics Ltd Corporation Information
6.1.2 Addex Therapeutics Ltd Overview
6.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales and Revenue in United States Market (2016-2021)
6.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Description
6.1.5 Addex Therapeutics Ltd Recent Developments
6.2 Bristol-Myers Squibb Company
6.2.1 Bristol-Myers Squibb Company Corporation Information
6.2.2 Bristol-Myers Squibb Company Overview
6.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales and Revenue in United States Market (2016-2021)
6.2.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Description
6.2.5 Bristol-Myers Squibb Company Recent Developments
6.3 Denovo Biopharma LLC
6.3.1 Denovo Biopharma LLC Corporation Information
6.3.2 Denovo Biopharma LLC Overview
6.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales and Revenue in United States Market (2016-2021)
6.3.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Description
6.3.5 Denovo Biopharma LLC Recent Developments
6.4 Domain Therapeutics SA
6.4.1 Domain Therapeutics SA Corporation Information
6.4.2 Domain Therapeutics SA Overview
6.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales and Revenue in United States Market (2016-2021)
6.4.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Description
6.4.5 Domain Therapeutics SA Recent Developments
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Corporation Information
6.5.2 Eli Lilly and Company Overview
6.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales and Revenue in United States Market (2016-2021)
6.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Description
6.5.5 Eli Lilly and Company Recent Developments
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Overview
6.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales and Revenue in United States Market (2016-2021)
6.6.4 Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Description
6.6.5 Johnson & Johnson Recent Developments
6.7 Merck & Co Inc
6.7.1 Merck & Co Inc Corporation Information
6.7.2 Merck & Co Inc Overview
6.7.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales and Revenue in United States Market (2016-2021)
6.7.4 Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Description
6.7.5 Merck & Co Inc Recent Developments

7 United States Metabotropic Glutamate Receptor 2 Production Capacity, Analysis
7.1 United States Metabotropic Glutamate Receptor 2 Production Capacity, 2016-2027
7.2 Metabotropic Glutamate Receptor 2 Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Metabotropic Glutamate Receptor 2 Supply Chain Analysis
9.1 Metabotropic Glutamate Receptor 2 Industry Value Chain
9.2 Metabotropic Glutamate Receptor 2 Upstream Market
9.3 Metabotropic Glutamate Receptor 2 Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Metabotropic Glutamate Receptor 2 Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

List of Tables
Table 1. Key Players of Metabotropic Glutamate Receptor 2 in United States Market
Table 2. Top Metabotropic Glutamate Receptor 2 Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Metabotropic Glutamate Receptor 2 Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Metabotropic Glutamate Receptor 2 Revenue Share by Companies, 2016-2021
Table 5. United States Metabotropic Glutamate Receptor 2 Sales by Companies, (K Pcs), 2016-2021
Table 6. United States Metabotropic Glutamate Receptor 2 Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Metabotropic Glutamate Receptor 2 Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Metabotropic Glutamate Receptor 2 Product Type
Table 9. List of Tier 1 Metabotropic Glutamate Receptor 2 Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Metabotropic Glutamate Receptor 2 Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of LY-2607540
Table 12. Major Manufacturers of BMT-133218
Table 13. By Type – United States Metabotropic Glutamate Receptor 2 Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Metabotropic Glutamate Receptor 2 Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Metabotropic Glutamate Receptor 2 Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Metabotropic Glutamate Receptor 2 Sales (K Pcs), 2016-2021
Table 17. By Type - United States Metabotropic Glutamate Receptor 2 Sales (K Pcs), 2022-2027
Table 18. By Application – United States Metabotropic Glutamate Receptor 2 Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Metabotropic Glutamate Receptor 2 Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Metabotropic Glutamate Receptor 2 Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Metabotropic Glutamate Receptor 2 Sales (K Pcs), 2016-2021
Table 22. By Application - United States Metabotropic Glutamate Receptor 2 Sales (K Pcs), 2022-2027
Table 23. Addex Therapeutics Ltd Corporation Information
Table 24. Addex Therapeutics Ltd Description and Major Businesses
Table 25. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product
Table 27. Addex Therapeutics Ltd Recent Developments
Table 28. Bristol-Myers Squibb Company Corporation Information
Table 29. Bristol-Myers Squibb Company Description and Major Businesses
Table 30. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product
Table 32. Bristol-Myers Squibb Company Recent Developments
Table 33. Denovo Biopharma LLC Corporation Information
Table 34. Denovo Biopharma LLC Description and Major Businesses
Table 35. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product
Table 37. Denovo Biopharma LLC Recent Developments
Table 38. Domain Therapeutics SA Corporation Information
Table 39. Domain Therapeutics SA Description and Major Businesses
Table 40. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product
Table 42. Domain Therapeutics SA Recent Developments
Table 43. Eli Lilly and Company Corporation Information
Table 44. Eli Lilly and Company Description and Major Businesses
Table 45. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product
Table 47. Eli Lilly and Company Recent Developments
Table 48. Johnson & Johnson Corporation Information
Table 49. Johnson & Johnson Description and Major Businesses
Table 50. Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Johnson & Johnson Metabotropic Glutamate Receptor 2 Product
Table 52. Johnson & Johnson Recent Developments
Table 53. Merck & Co Inc Corporation Information
Table 54. Merck & Co Inc Description and Major Businesses
Table 55. Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. Merck & Co Inc Metabotropic Glutamate Receptor 2 Product
Table 57. Merck & Co Inc Recent Developments
Table 58. Metabotropic Glutamate Receptor 2 Production Capacity (K Pcs) of Key Manufacturers in United States Market, 2019-2021 (K Pcs)
Table 59. United States Metabotropic Glutamate Receptor 2 Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Metabotropic Glutamate Receptor 2 Market Opportunities & Trends in United States Market
Table 61. Metabotropic Glutamate Receptor 2 Market Drivers in United States Market
Table 62. Metabotropic Glutamate Receptor 2 Market Restraints in United States Market
Table 63. Metabotropic Glutamate Receptor 2 Raw Materials
Table 64. Metabotropic Glutamate Receptor 2 Raw Materials Suppliers in United States Market
Table 65. Typical Metabotropic Glutamate Receptor 2 Downstream
Table 66. Metabotropic Glutamate Receptor 2 Downstream Clients in United States Market
Table 67. Metabotropic Glutamate Receptor 2 Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Metabotropic Glutamate Receptor 2 Product Picture
Figure 2. Metabotropic Glutamate Receptor 2 Segment by Type
Figure 3. Metabotropic Glutamate Receptor 2 Segment by Application
Figure 4. United States Metabotropic Glutamate Receptor 2 Market Overview: 2020
Figure 5. United States Metabotropic Glutamate Receptor 2 Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Metabotropic Glutamate Receptor 2 Revenue, 2016-2027 (US$, Mn)
Figure 7. Metabotropic Glutamate Receptor 2 Sales in United States Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Metabotropic Glutamate Receptor 2 Revenue in 2020
Figure 9. LY-2607540 Product Picture
Figure 10. BMT-133218 Product Picture
Figure 11. DT-2442 Product Picture
Figure 12. JNJ-40411813 Product Picture
Figure 13. Others Product Picture
Figure 14. By Type - United States Metabotropic Glutamate Receptor 2 Sales Market Share, 2016-2027
Figure 15. By Type - United States Metabotropic Glutamate Receptor 2 Revenue Market Share, 2016-2027
Figure 16. By Type - United States Metabotropic Glutamate Receptor 2 Price (USD/Pcs), 2016-2027
Figure 17. Anxiety Disorders
Figure 18. Depression
Figure 19. Schizophrenia
Figure 20. Chronic Pain
Figure 21. Others
Figure 22. By Application - United States Metabotropic Glutamate Receptor 2 Sales Market Share, 2016-2027
Figure 23. By Application - United States Metabotropic Glutamate Receptor 2 Revenue Market Share, 2016-2027
Figure 24. By Application - United States Metabotropic Glutamate Receptor 2 Price (USD/Pcs), 2016-2027
Figure 25. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Johnson & Johnson Metabotropic Glutamate Receptor 2 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Merck & Co Inc Metabotropic Glutamate Receptor 2 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. United States Metabotropic Glutamate Receptor 2 Production Capacity (K Pcs), 2016-2027
Figure 33. Metabotropic Glutamate Receptor 2 Industry Value Chain
Figure 34. Marketing Channels

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.